Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


MICHELSON DIAGNOSTICS announces launch of VivoSight Multi-Beam OCT scanner


Michelson Diagnostics Limited (MDL), the UK manufacturer of Multi-Beam Optical Coherence Tomography (OCT) scanners, is pleased to formally announce the launch of its ‘VivoSight’ Multi-Beam OCT scanner. The scanner uses the high resolution capability of the company’s proprietary Multi-Beam OCT technology, to provide state-of-the art images of skin and other surface tissue through the use of a compact, ergonomically designed hand-held probe.

The probe is designed for use on external tissue such as for imaging skin microstructure, with an isotropic resolution of better than 10 µm to a depth of up to 2 mm. Scan rates vary from 6.5 fps to 35 fps, depending on the scan width, which, in turn, can be varied up to 5 mm. The probe has full x-y scanning capability enabling rapid capture of 3D TIFF format image stacks up to 5 mm x 5 mm, with a pixel size of 4 µm. A specially designed adjustable stand-off enables image capture from awkward locations without subject discomfort. The software is designed to be quick and easy to understand and use, and does not require an in-depth understanding of OCT.

The probe will be suitable for many skin measurement and analysis tasks, especially those that require detailed images of sub-surface skin microstructure, at resolutions currently out of reach of ultrasound and MRI, and depths beyond that accessible with confocal microscopy.

In the USA, the scanner is currently only available for non-clinical applications (a 510(k) application is planned), but in Europe, clinical orders are now being taken.

Michelson Diagnostics is leading the way in applying Multi-Beam OCT to the diagnosis, monitoring and treatment of cancer, particularly dermal and oral cancer. MDL is working closely with leading clinicians, who believe that Multi-Beam OCT, by providing a new, detailed window into the body, will accelerate the care of cancer, enabling faster, more accurate treatment that will save lives and produce substantial cost savings to the medical services. Clinical trials are under way. It provides double the lateral image resolution of conventional single-beam OCT which is crucial to providing crisp, clear images of the subject matter micro-structure.

For further details about OCT and Michelson Diagnostics, please visit the MDL web site, www.michelsondiagnostics.com. Alternatively, you may email your questions to enquiries@md-ltd.co.uk.


Publisher Contact Information:

Michelson Diagnostics
0 208 308 1695
jon.holmes@md-ltd.co.uk

Company profile of Michelson Diagnostics
Past press releases of Michelson Diagnostics.

Data


26,673
Tech investments
From our Online Data Service
17,217
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Nov 25€24.0MInternet commerce
Feb 14€19.0MBiopharmaceuticals
Feb 14N/AInternet services
Feb 14€4.6MBusiness applications
Feb 13€13.0MBiopharmaceuticals
Feb 13€25.0MMedical devices
Feb 13€15.0MBusiness applications

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Jan 29
Yumpingo
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.